Back to search results

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Small Cell Lung Cancer · Advanced Solid Malignant Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • California Cancer Associates-Encintas, Encinitas, California, United States

    Contact: Study coordinator (Christina Spencer) · CSpencer@ccare.com · 760-452-3909
    Contact: Principal Investigator (Alberto Besseduo, MD)

  • Providence/St. Joe Cancer Institute/Crosson Cancer Institute, Fullerton, California, United States

    Contact: Study coordinator (Mirza "Hadi" Al Baig) · mirza.baig@providence.org
    Contact: Principal Investigator (Yung Lyou, MD)

  • Winship Cancer Institute of Emory University, Atlanta, Georgia, United States

    Contact: Study coordinator (Mashunte Holmes) · mashunte.holmes@emory.edu
    Contact: Principal Investigator (Jennifer Carlisle)

  • Dana Farber Cancer Institue, Boston, Massachusetts, United States

    Contact: Study coordinator (Diandra Ocot) · Diandra_ocot@dfci.harvard.edu
    Contact: Principal Investigator (Jacob Sands, MD)

  • Karmanos Cancer Institute, Detroit, Michigan, United States

    Contact: Study coordinator (Hirva Mamdani, MD) · mamdanih@karmanos.org · 313-576-8711
    Contact: Principal Investigator (Hirva Mamdani, MD)

  • Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States

    Contact: Study coordinator (Ann Lovelace) · Ann.Lovelace@usoncology.com · 702-952-3449
    Contact: Principal Investigator (Liawaty Ho)

  • Gabrail Cancer Center Research, Canton, Ohio, United States

    Contact: Study coordinator (Nashat Gabrail, MD) · research@gabrailcancercenter.com · 330-492-3345
    Contact: Principal Investigator (Nashat Gabrail, MD)

  • OU Health, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Christina Caldwell) · Christina-Caldwell@ouhsc.edu · 405-271-8001
    Contact: Principal Investigator (Abdul Rafeh Naqash)

  • Sarah Cannon Research Center, Nashville, Tennessee, United States

    Contact: Study coordinator (David R Spigel, MD) · david.spigel@sarahcannon.com · 615-329-7294

  • North Houston Cancer Clinics, Huntsville, Texas, United States

    Contact: Study coordinator (Elham Abbasi, MD) · eli@nhcancerclinics.com · 936-439-5213
    Contact: Study coordinator (Roham Garvashi, MD) · rdarvishi@nhcancerclinics.com · (936)439-5213
    Contact: Principal Investigator (Elham Abbasi, MD)

  • Virginia Cancer Specialists, Fairfax, Virginia, United States

    Contact: Study coordinator (Carrie Friedman) · Carrie.Friedman@usoncology.com
    Contact: Principal Investigator (Alexander Spira, MD)
Study leads

  • Cabilia Pichardo, MD

    Study Director

    Executive Director of Clinical Development

View source on ClinicalTrials.gov(opens in a new tab)